---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-017172"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T01:54:55.224647+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical Q1 net sales up 16% to $73.5M; raises FY2023 outlook to $348M

## Summary
- ICL sales of $70.6M up 20% YoY; ICL units also up 20%.
- GAAP EPS $0.05 vs $0.19; adjusted EPS $0.18 vs $0.29.
- Fiscal 2023 net sales outlook raised to $348M from $340M, implying 28% ICL growth.
- Gross margin improved to 78.3% from 77.9%.
- Cash & investments at $217.3M, down from $225.5M at Q4 2022.

## SEC filing metadata
- accession: 0000950170-23-017172
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000095017023017172/0000950170-23-017172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000095017023017172/staa-20230503.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-017172
- JSON: https://secwatch.observer/filing/0000950170-23-017172.json
- Plain text: https://secwatch.observer/filing/0000950170-23-017172.txt

## Key facts
- Earnings Releases
  STAAR SURGICAL CO reported first quarter ended March 31, 2023 results: revenue $73.5 million, net income $2.7 million or $0.05 per diluted share, EPS $0.05 per diluted share. Guidance raised.
  - Period: first quarter ended March 31, 2023
  - Revenue: $73.5 million
  - Net income: $2.7 million or $0.05 per diluted share
  - EPS: $0.05 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: in the filing unless specifically stated so therein . --- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 STAAR Surgical Reports First Quarter 2023 Results Q1 2023 Net Sales of $73.5 Million; ICL Sales of $70.6 Million Up 20% Y/Y Fiscal 2023 Net Sales Outlook Raised to $348 Million; ICL Sales to $345 Million Up 28% Y/Y LAKE FOREST, CA, May 3, 2023 --- STAAR Surgical
  evidence_url: https://www.sec.gov/Archives/edgar/data/718937/000095017023017172/0000950170-23-017172-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.